Quick Answer
KYNTRA BIO, INC. reported Operating Income of -$45.90 million for fiscal year 2025.
KYNTRA BIO, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$45.90M | +69.5% |
| 2024 | -$150.42M | +53.4% |
| 2023 | -$322.72M | -7.2% |
| 2022 | -$301.02M | -4.3% |
| 2021 | -$288.53M | -50.4% |
| 2020 | -$191.88M | -114.8% |
| 2019 | -$89.31M | -3.0% |
| 2018 | -$86.69M | +26.1% |
| 2017 | -$117.28M | -134.4% |
| 2016 | -$50.04M | +35.5% |
| 2015 | -$77.62M | -54.9% |
| 2014 | -$50.10M | -530.3% |
| 2013 | -$7.95M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.41M | +88.7% | +55.1% |
| June 30, 2025 | -$12.05M | +74.0% | +19.2% |
| March 31, 2025 | -$14.92M | +69.7% | +68.7% |
| September 30, 2024 | -$47.69M | +24.9% | -2.8% |
| June 30, 2024 | -$46.41M | +47.3% | +5.6% |
| March 31, 2024 | -$49.18M | +35.4% | +22.5% |
| September 30, 2023 | -$63.48M | +32.2% | +27.9% |
| June 30, 2023 | -$88.05M | -12.6% | -15.7% |
- KYNTRA BIO, INC. showed an increase of +69.5% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, KYNTRA BIO, INC.’s operating income has declined by 477.4% (from -$7.95 million to -$45.90 million).
- The most recent figure is from KYNTRA BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: